Laddar...
Nocturnal Glycemic Control with New Insulin Glargine 300 U/mL
Insulin glargine 300 U/mL (Gla-300) is a new generation basal insulin product that has been demonstrated to have more stable pharmacokinetic and pharmacodynamic characteristics than insulin glargine 100 U/mL (Gla-100). To evaluate the real-world benefits of Gla-300 in reducing nocturnal fluctuations...
Sparad:
| I publikationen: | Adv Med |
|---|---|
| Huvudupphovsman: | |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Hindawi
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6617920/ https://ncbi.nlm.nih.gov/pubmed/31346529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/8587265 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|